| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a0e031656a2cfb2972082710f19d618 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate |
2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e567f42b990bd4e0c1bfc5689a4955c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de981ccd229028eca43b58517e827ceb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9769d98371ee7056b3bf7c96dc239f9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38552ba781acb8c689f6fd3ab2327923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c11dbb5d39d89b95c0d44f5467c5c0df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6926a7ddd89d3a7abd17cc208e4046cd |
| publicationDate |
2022-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4099986-A2 |
| titleOfInvention |
Xanthan-based ophthalmic topical formulations with a reduced dosage regimen |
| abstract |
The present invention relates to formulations for ophthalmic use characterized by a reduced dosage regimen. |
| priorityDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |